Related Experiment Video
Updated: Jun 26, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Peroxisome proliferator-activated receptors and hepatitis C virus-induced insulin resistance
1Viropathology Unit, University of Geneva Medical Center, 1211 Geneva, Switzerland. francesco.negro@hcuge.ch
Abstract:
Insulin resistance and type 2 diabetes are associated with hepatitis C virus infection. A wealth of clinical and experimental data suggests that the virus is directly interfering with the insulin signalling in hepatocytes. In the case of at least one viral genotype (the type 3a), insulin resistance seems to be directly mediated by the downregulation of the peroxisome proliferator-activated receptor gamma. Whether and how this interaction may be manipulated pharmacologically, in order to improve the responsiveness to antivirals of insulin resistant chronic hepatitis C, patients remain to be fully explored.
Insights
Hepatitis C virus infection is linked to insulin resistance and type 2 diabetes. The virus may directly impair insulin signaling in liver cells, particularly genotype 3a, by reducing peroxisome proliferator-activated receptor gamma.
Area of Science:
- Hepatology
- Endocrinology
- Virology
Background:
- Insulin resistance and type 2 diabetes are common in patients with chronic hepatitis C virus (HCV) infection.
- Clinical and experimental evidence suggests a direct role of HCV in disrupting insulin signaling pathways within hepatocytes.
Purpose of the Study:
- To investigate the direct mechanisms by which HCV influences insulin resistance.
- To explore the role of peroxisome proliferator-activated receptor gamma (PPAR-γ) in HCV-associated insulin resistance.
- To assess the potential for pharmacological interventions targeting this interaction.
Main Methods:
- Review of existing clinical and experimental data on HCV and insulin resistance.
- Analysis of viral genotype-specific effects on insulin signaling.
- Examination of the role of PPAR-γ downregulation in insulin resistance.
Main Results:
- HCV infection is strongly associated with impaired insulin sensitivity and type 2 diabetes.
- The virus appears to directly interfere with hepatic insulin signaling pathways.
- HCV genotype 3a specifically downregulates PPAR-γ, a key regulator of insulin sensitivity.
Conclusions:
- HCV directly contributes to insulin resistance in hepatocytes.
- PPAR-γ downregulation is a potential mechanism for HCV-induced insulin resistance, particularly with genotype 3a.
- Further research is needed to explore pharmacological strategies to improve antiviral treatment outcomes in insulin-resistant HCV patients.
Related Concept Videos
Hepatitis
Insulin: The Receptor and Signaling Pathways
Peroxisomes
Chronic Pancreatitis II: Pathophysiology
Viral Hepatitis I: Introduction
Cell Specific Gene Expression

